berberine has been researched along with decanoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fan, Z; Li, J; Lv, XY; Wang, CM; Wang, CY; Zhang, M | 1 |
| Chang, W; Chen, L; Li, J; Li, W; Liu, Y; Lv, X; Meng, Z; Wang, Q; Zhang, M | 1 |
| Dong, W; Fan, D; Li, J; Sun, W; Tang, X; Wu, X | 1 |
| Hatch, GM; Jingkai, G; Li, C; Ming, Z; Shengnan, W; Xiaojia, B; Zhaojie, M | 1 |
| Chen, L; Chen, W; Hatch, GM; Wei, S; Xiao, J; Xue, H; Yao, F; Yu, Y; Zhang, M | 1 |
5 other study(ies) available for berberine and decanoic acid
| Article | Year |
|---|---|
Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
Topics: Absorption; Animals; Berberine; Biological Availability; Decanoic Acids; Duodenum; Hypoglycemic Agents; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Intestines; Jejunum; Male; Medicine, Chinese Traditional; Random Allocation; Rats; Rats, Wistar | 2010 |
Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
Topics: Adenylate Kinase; Animals; Area Under Curve; Berberine; Blood Glucose; Decanoic Acids; Diabetes Mellitus, Experimental; Drug Synergism; Drug Therapy, Combination; Gene Expression; Gluconeogenesis; Glucose; Glucose Tolerance Test; Glucose-6-Phosphatase; Hep G2 Cells; Humans; Hypoglycemic Agents; Lipid Metabolism; Liver; Male; Mechanistic Target of Rapamycin Complex 2; Multiprotein Complexes; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphoenolpyruvate Carboxykinase (GTP); Phosphorylation; Protein Processing, Post-Translational; Rats; Rats, Wistar; RNA-Binding Proteins; TOR Serine-Threonine Kinases; Transcription Factors | 2012 |
Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Berberine; Biological Availability; Decanoic Acids; Deoxycholic Acid; Excipients; Intestinal Absorption; Intestinal Mucosa; Magnetic Resonance Spectroscopy; Male; Random Allocation; Rats; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Up-Regulation | 2013 |
Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Topics: Administration, Oral; Animals; Berberine; Biological Availability; Blood Glucose; Caco-2 Cells; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallography, X-Ray; Decanoic Acids; Diabetes Mellitus, Type 2; Disease Models, Animal; Excipients; Humans; Hypoglycemic Agents; Intestinal Absorption; Lipids; Male; Microscopy, Electron, Scanning; Permeability; Powder Diffraction; Rats, Wistar; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2014 |
Pretreatment of rats with increased bioavailable berberine attenuates cerebral ischemia-reperfusion injury via down regulation of adenosine-5'monophosphate kinase activity.
Topics: Animals; Apoptosis; Berberine; Biological Availability; Brain; Cyclic AMP-Dependent Protein Kinases; Decanoic Acids; Down-Regulation; Male; Malondialdehyde; Myocardial Reperfusion Injury; Nitric Oxide; PC12 Cells; Rats | 2016 |